{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:31:33Z","timestamp":1787909493571,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Swiss National Sciences Foundation","award":["PZ00P3_179919"],"award-info":[{"award-number":["PZ00P3_179919"]}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"crossref","award":["NU21-05-00143"],"award-info":[{"award-number":["NU21-05-00143"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"crossref","award":["NU21-05-00143"],"award-info":[{"award-number":["NU21-05-00143"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92560-1","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T01:30:51Z","timestamp":1741656651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tick-borne encephalitis virus seroprevalence and infection incidence in Switzerland, 2020\u20132021"],"prefix":"10.1038","volume":"15","author":[{"given":"Arthur","family":"Br\u00eachet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Gr\u00e4ssli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Vock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Sal\u00e1t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"R\u016f\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9e","family":"Friedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vuichard-Gysin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Croxatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Lienhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahel","family":"Ackermann-G\u00e4umann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"92560_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.antiviral.2019.01.014","volume":"164","author":"D Ruzek","year":"2019","unstructured":"Ruzek, D. et al. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 164, 23\u201351 (2019).","journal-title":"Antiviral Res."},{"issue":"5","key":"92560_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.12998\/wjcc.v3.i5.430","volume":"3","author":"P Bogovic","year":"2015","unstructured":"Bogovic, P. & Strle, F. Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World J Clin Cases. 3(5), 430\u2013441 (2015).","journal-title":"World J Clin Cases."},{"issue":"2","key":"92560_CR3","first-page":"100","volume":"21","author":"R Ackermann-Gaumann","year":"2023","unstructured":"Ackermann-Gaumann, R. et al. Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014\u20132015. Blood Transfus. 21(2), 100\u2013109 (2023).","journal-title":"Blood Transfus."},{"key":"92560_CR4","unstructured":"BAG. Zahlen zu Infektionskrankheiten Zeckenenzephalitis FSME: Swiss Federal Office of Public Health; [Available from: https:\/\/www.bag.admin.ch\/bag\/de\/home\/zahlen-und-statistiken\/zahlen-zu-infektionskrankheiten.exturl.html\/aHR0cHM6Ly9tZWxkZXN5c3RlbWUuYmFnYXBwcy5jaC9pbmZyZX\/BvcnRpbmcvZGF0ZW5kZXRhaWxzL2QvZnNtZS5odG1sP3dlYmdy\/YWI9aWdub3Jl.html."},{"issue":"2","key":"92560_CR5","first-page":"51","volume":"52","author":"J Lun\u00e1ckov\u00e1","year":"2003","unstructured":"Lun\u00e1ckov\u00e1, J., Chmel\u00edk, V., S\u00edpov\u00e1, I., Zampachov\u00e1, E. & Becv\u00e1rov\u00e1, J. Epidemiologic monitoring of tick-borne encephalitis in Rimov in Southern Bohemia. Epidemiol. Mikrobiol. Imunol. 52(2), 51\u201358 (2003).","journal-title":"Epidemiol. Mikrobiol. Imunol."},{"key":"92560_CR6","doi-asserted-by":"publisher","first-page":"1352720","DOI":"10.3389\/fimmu.2024.1352720","volume":"15","author":"R Ackermann-Gaumann","year":"2024","unstructured":"Ackermann-Gaumann, R., Lang, P. & Zens, K. D. Defining the \u201cCorrelate(s) of Protection\u201d to tick-borne encephalitis vaccination and infection - key points and outstanding questions. Front. Immunol. 15, 1352720 (2024).","journal-title":"Front. Immunol."},{"key":"92560_CR7","unstructured":"Federal Office for Public Health Switzerland. Cantonal vaccination monitoring. Available online: https:\/\/www.bag.admin.ch\/bag\/de\/home\/gesund-leben\/gesundheitsfoerderung-und-praevention\/impfungen-prophylaxe\/informationen-fachleute-gesundheitspersonal\/durchimpfung.html. Accessed on 06.02.2024. 2022."},{"issue":"49","key":"92560_CR8","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1016\/j.vaccine.2020.10.022","volume":"38","author":"V Baroutsou","year":"2020","unstructured":"Baroutsou, V., Zens, K. D., Sinniger, P., Fehr, J. & Lang, P. Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018. Vaccine 38(49), 7825\u20137833 (2020).","journal-title":"Vaccine"},{"issue":"1","key":"92560_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/vaccines8010081","volume":"8","author":"J Salat","year":"2020","unstructured":"Salat, J. et al. Tick-borne encephalitis virus vaccines contain non-structural protein 1 antigen and may elicit NS1-specific antibody responses in vaccinated individuals. Vaccines 8(1), 81 (2020).","journal-title":"Vaccines"},{"issue":"2","key":"92560_CR10","doi-asserted-by":"publisher","first-page":"2300221","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300221","volume":"29","author":"B Albinsson","year":"2024","unstructured":"Albinsson, B. et al. Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019. Eurosurveillance 29(2), 2300221 (2024).","journal-title":"Eurosurveillance"},{"key":"92560_CR11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.12.2200408","author":"K Euringer","year":"2023","unstructured":"Euringer, K. et al. Tick-borne encephalitis virus IgG antibody surveillance: vaccination- and infection-induced seroprevalences, south-western Germany, 2021. Eurosurveillance https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.12.2200408 (2023).","journal-title":"Eurosurveillance"},{"key":"92560_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2023.114831","volume":"322","author":"R Ackermann-Gaumann","year":"2023","unstructured":"Ackermann-Gaumann, R. et al. Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response. J Virol Methods. 322, 114831 (2023).","journal-title":"J Virol Methods."},{"issue":"1","key":"92560_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12916-021-02144-9","volume":"19","author":"P Kohler","year":"2021","unstructured":"Kohler, P. et al. Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19-a prospective multicenter cohort study. BMC Med. 19(1), 270 (2021).","journal-title":"BMC Med."},{"key":"92560_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105941","volume":"228","author":"M Zimna","year":"2024","unstructured":"Zimna, M., Brzuska, G., Salat, J., Ruzek, D. & Krol, E. Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles - A recombinant vaccine candidate. Antiviral Res. 228, 105941 (2024).","journal-title":"Antiviral Res."},{"key":"92560_CR15","doi-asserted-by":"crossref","unstructured":"Erber W, Schmitt HJ, Jankovic TV. TBE-epidemiology by country\u2014an overview. Chapter 12a. In: Dobler G, Erber W, Br\u00f6ker M, Schmitt HJ, editors. The TBE Book. Singapore: Global Health Press; 2023.","DOI":"10.33442\/26613980_12a-6"},{"issue":"8","key":"92560_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/vaccines10081294","volume":"10","author":"E Bojkiewicz","year":"2022","unstructured":"Bojkiewicz, E. et al. The prevalence of asymptomatic infections with tick-borne encephalitis virus and attitude towards tick-borne encephalitis vaccine in the endemic area of northeastern Poland. Vaccines 10(8), 1294. https:\/\/doi.org\/10.3390\/vaccines10081294 (2022).","journal-title":"Vaccines"},{"issue":"4","key":"92560_CR17","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ttbdis.2018.03.031","volume":"9","author":"R Ackermann-Gaumann","year":"2018","unstructured":"Ackermann-Gaumann, R., Tritten, M. L., Hassan, M. & Lienhard, R. Comparison of three commercial IgG and IgM ELISA kits for the detection of tick-borne encephalitis virus antibodies. Ticks Tick Borne Dis. 9(4), 956\u2013962 (2018).","journal-title":"Ticks Tick Borne Dis."},{"issue":"21\u201322","key":"92560_CR18","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","volume":"22","author":"P Rendi-Wagner","year":"2004","unstructured":"Rendi-Wagner, P. et al. Persistence of protective immunity following vaccination against tick-borne encephalitis\u2013longer than expected?. Vaccine. 22(21\u201322), 2743\u20132749 (2004).","journal-title":"Vaccine."},{"issue":"4","key":"92560_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.vaccine.2004.07.002","volume":"23","author":"P Rendi-Wagner","year":"2004","unstructured":"Rendi-Wagner, P. et al. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation. Vaccine 23(4), 427\u2013434 (2004).","journal-title":"Vaccine"},{"issue":"6","key":"92560_CR20","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.vaccine.2008.11.082","volume":"27","author":"A Plentz","year":"2009","unstructured":"Plentz, A., Jilg, W., Schwarz, T. F., Kuhr, H. B. & Zent, O. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults. Vaccine 27(6), 853\u2013856 (2009).","journal-title":"Vaccine"},{"issue":"3","key":"92560_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.vaccine.2004.06.007","volume":"23","author":"O Zent","year":"2004","unstructured":"Zent, O. et al. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?. Vaccine 23(3), 312\u2013315 (2004).","journal-title":"Vaccine"},{"issue":"Suppl","key":"92560_CR22","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.21101\/cejph.a5271","volume":"26","author":"E Dorko","year":"2018","unstructured":"Dorko, E. et al. Effectiveness of primary vaccination against tick-borne encephalitis in employees of the armed forces. Cent Eur J Public Health 26(Suppl), S42\u2013S46 (2018).","journal-title":"Cent Eur J Public Health"},{"issue":"3","key":"92560_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.vaccine.2011.11.061","volume":"30","author":"HH Askling","year":"2012","unstructured":"Askling, H. H., Vene, S., Rombo, L. & Lindquist, L. Immunogenicity of delayed TBE-vaccine booster. Vaccine 30(3), 499\u2013502 (2012).","journal-title":"Vaccine"},{"issue":"8","key":"92560_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jmv.23313","volume":"84","author":"T Baldovin","year":"2012","unstructured":"Baldovin, T. et al. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection. J. Med. Virol. 84(8), 1274\u20131278 (2012).","journal-title":"J. Med. Virol."},{"issue":"8","key":"92560_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1089\/vbz.2014.1747","volume":"15","author":"B Kriz","year":"2015","unstructured":"Kriz, B. et al. Results of the screening of tick-borne encephalitis virus antibodies in human sera from eight districts collected two decades apart. Vector Borne Zoonotic Dis. 15(8), 489\u2013493 (2015).","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"9","key":"92560_CR26","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/14760584.2017.1358620","volume":"16","author":"I Galgani","year":"2017","unstructured":"Galgani, I. et al. Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules. Exp. Rev. Vaccines 16(9), 919\u2013932 (2017).","journal-title":"Exp. Rev. Vaccines"},{"issue":"43","key":"92560_CR27","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","volume":"29","author":"A Loew-Baselli","year":"2011","unstructured":"Loew-Baselli, A. et al. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme. Vaccine 29(43), 7307\u20137319 (2011).","journal-title":"Vaccine"},{"issue":"5","key":"92560_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2021.101779","volume":"12","author":"R Steffen","year":"2021","unstructured":"Steffen, R., Erber, W. & Schmitt, H. J. Can the booster interval for the tick-borne encephalitis (TBE) vaccine \u201cFSME-IMMUN\u201d be prolonged? - A systematic review. Ticks Tick Borne Dis. 12(5), 101779 (2021).","journal-title":"Ticks Tick Borne Dis."},{"issue":"4","key":"92560_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061228","volume":"12","author":"KD Zens","year":"2022","unstructured":"Zens, K. D. et al. Retrospective, matched case-control analysis of tickborne encephalitis vaccine effectiveness by booster interval, Switzerland 2006\u20132020. BMJ Open. 12(4), e061228 (2022).","journal-title":"BMJ Open."},{"issue":"11","key":"92560_CR30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1432-2277.2009.00927.x","volume":"22","author":"D Weiskopf","year":"2009","unstructured":"Weiskopf, D., Weinberger, B. & Grubeck-Loebenstein, B. The aging of the immune system. Transpl Int. 22(11), 1041\u20131050 (2009).","journal-title":"Transpl Int."},{"key":"92560_CR31","unstructured":"Switzerland FOfPH. Vaccination protects against TBE: reporting data Switzerland, 2002 - 2015. BAG Bulletin. 2016;41:622\u20136."},{"key":"92560_CR32","unstructured":"Zens KD. TBE in Switzerland and Liechtenstein. Chapter 13. . In: Dobler G, Erber W, Br\u00f6cker M, Chitimia-Dobler L, Schmitt HJ, editors. The TBE Book. 7 ed. Singapore: Global Health Press; 2024."},{"key":"92560_CR33","doi-asserted-by":"crossref","unstructured":"Freimane Z, Dobler G, Chitimia-Dobler L, Karelis G, Girl P, Kuzmane S, et al. Development and validation of a novel enzyme-linked immunosorbent assay for the differentiation of tick-borne encephalitis infections caused by different virus subtypes. Infection. 2024.","DOI":"10.21203\/rs.3.rs-4546509\/v1"},{"issue":"1","key":"92560_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1128\/CVI.00347-07","volume":"15","author":"E Konishi","year":"2008","unstructured":"Konishi, E., Kitai, Y. & Kondo, T. Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: application to nonstructural protein 1 in a model of Japanese encephalitis virus. Clin. Vaccine Immunol. 15(1), 88\u201394 (2008).","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"92560_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/JCM.02735-14","volume":"53","author":"DY Chao","year":"2015","unstructured":"Chao, D. Y., Galula, J. U., Shen, W. F., Davis, B. S. & Chang, G. J. Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans. J. Clin. Microbiol. 53(2), 557\u2013566 (2015).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92560-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92560-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92560-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:01:52Z","timestamp":1741698112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92560-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92560"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92560-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RA-G reports honoraria for lectures and\/or research grants from Pfizer and Bavarian Nordic, which do, however, not relate to the present work. RL reports honoraria for presentations and discussions on the impact and prevention of different tick-borne diseases and the epidemiology of Lyme disease, which do also not relate to the present work. The other authors report no conflicting interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethics committee of Eastern Switzerland (#2020\u201300502). All study data were pseudonymized and REDCap was used for data collection. REDCap is a secure and established web application for clinical studies, compliant with the International Council on Harmonization of Good Clinical Practice (ICH-GCP).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"8346"}}